InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the full record of transactions filed by Martinez Maria E, 董事. Insider active across 1 company, notably Mirati Therapeutics, Inc.. In total, 4 disclosures have been published. History available since 14 January 2022. The latest transaction was filed on 29 December 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Martinez Maria E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
6,021 股Common StockSEC:0001140361-24-003539:0
6,808 股@ US$58.75100.0% 占其流量Common StockSEC:0001628280-24-000319:0
4,444 股0Common StockSEC:0001214659-23-001039:0
2,546 股0Common StockSEC:0001214659-22-000845:0
4 条申报中的 4 条
About Martinez Maria E
Maria E. Martinez is a Director at Mirati Therapeutics, Inc. She participates in the governance of the company, bringing her expertise in biotechnology and strategy. Her role is essential for guiding strategic decisions.
